Mustafa A. Reheim-Abdel
Shaqra', 11961, Saudi Arabia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 98 publications
Correction: Mohammed et al. Alvespimycin Exhibits Potential Anti-TGF-β Signaling in the Setting of a Proteasome Activator in Rats with Bleomycin-Induced Pulmonary Fibrosis: A Promising Novel Approach. Pharmaceuticals 2023, 16, 1123.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: June 26, 2025
Targeting miRNAs in renal cell carcinoma: emerging therapeutic strategies.
Journal: International journal of clinical oncology
Published: June 22, 2025
Global Perspectives on Coronary Artery Disease: The Emerging Role of miRNAs.
Journal: Current atherosclerosis reports
Published: May 29, 2025
Unraveling the therapeutic landscape of miRNAs in pancreatic cancer.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: May 02, 2025
Diabetic retinopathy in focus: Update on treatment advances, pharmaceutical approaches, and new technologies.
Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
Published: May 01, 2025
miRNA dysregulation in depression: unraveling the interplay between neuroplasticity, HPA axis dysfunction, and neuroinflammation.
Journal: Metabolic brain disease
Published: April 21, 2025
The Role of MiRNAs in Moyamoya Disease: Vascular Remodeling and Stroke Risk.
Journal: The journal of gene medicine
Published: April 16, 2025
Activation of nicotinamide phosphoribosyltransferase protects against unilateral renal ischemia-reperfusion injury via the NAD+/SIRT1/PGC-1α signaling pathway and modulation of NFκB/TNF-α/IL-6.
Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
Published: March 31, 2025
Dual-sensitive gelatin-coated chitosan microparticles for targeted semaglutide pulmonary delivery: a novel approach to enhancing anti-inflammatory and anti-fibrotic effects.
Journal: International immunopharmacology
Published: March 27, 2025
miRNAs as Biomarkers and Therapeutic Targets in Celiac Disease: Current Advances and Future Directions.
Journal: Journal of biochemical and molecular toxicology
Published: March 17, 2025
The role of miRNAs in pathogenesis, diagnosis, and therapy of Helicobacter pylori infection, gastric cancer-causing bacteria: Special highlights on nanotechnology-based therapy.
Journal: Microbial pathogenesis
Published: February 13, 2025
Last Updated: 09/26/2026